TriReme CE marks Antares coronary stent system
This article was originally published in Clinica
Executive Summary
TriReme Medical has CE marked its Antares coronary stent system, which is designed for use at or near coronary bifurcations, for sale in Europe. Antares fits all classes of bifurcation lesions, irrespective of the size and angle of the side-branch, the Pleasanton, California firm says. It can be delivered and deployed in a single step while maintaining access to the side-branch, meaning the physician can deploy a second stent in the side-branch if necessary. TriReme claims it could be used in a quarter of the 2.2 million angioplasty procedures performed annually worldwide. The system is not yet approved in the US.